Regulation of Developmental Lymphangiogenesis by Syk+ Leukocytes

Developmental Cell

Volumn 18, Issue 3, 2010, Pages 437-449

  Böhmer, Ruben ^a   Neuhaus, Brit ^a   Bühren, Sebastian ^a   Zhang, Dayong ^a   Stehling, Martin ^a   Böck, Barbara ^a,b   Kiefer, Friedemann ^a  

^a MAX PLANCK INSTITUTE FOR MOLECULAR BIOMEDICINE   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

DEVBIO

Indexed keywords

EPHRIN RECEPTOR B4; FIBROBLAST GROWTH FACTOR 2; GELATINASE A; GELATINASE B; MONOCYTE CHEMOTACTIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR B; PROTEIN KINASE SYK; TISSUE INHIBITOR OF METALLOPROTEINASE 1; VASCULOTROPIN C; VASCULOTROPIN D; VASCULOTROPIN RECEPTOR 2; CHEMOKINE; PHOTOPROTEIN; PRIMER DNA; PROTEIN TYROSINE KINASE; RECOMBINANT PROTEIN; SIGNAL PEPTIDE; VASCULAR ENDOTHELIAL GROWTH FACTOR C, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CONGENITAL BLOOD VESSEL MALFORMATION; CONTROLLED STUDY; EMBRYO; ENDOTHELIAL PROGENITOR CELL; GENE DELETION; GENE MAPPING; HEMATOPOIETIC CELL; IN VIVO STUDY; LEUKOCYTE; LYMPHANGIOGENESIS; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REGULATORY MECHANISM; UPREGULATION; ANIMAL; BLOOD VESSEL; FEMALE; GENE EXPRESSION REGULATION; GENETICS; LYMPH VESSEL; MALE; METABOLISM; MOUSE MUTANT; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; PREGNANCY; PRENATAL DEVELOPMENT; SKIN; TRANSGENIC MOUSE; VASCULARIZATION;

ANIMALS; BASE SEQUENCE; BLOOD VESSELS; CHEMOKINES; DNA PRIMERS; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LEUKOCYTES; LUMINESCENT PROTEINS; LYMPHANGIOGENESIS; LYMPHATIC VESSELS; MALE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MODELS, ANIMAL; MYELOID CELLS; PREGNANCY; PROMOTER REGIONS, GENETIC; PROTEIN-TYROSINE KINASES; RECOMBINANT PROTEINS; SKIN; VASCULAR ENDOTHELIAL GROWTH FACTOR C; VASCULAR ENDOTHELIAL GROWTH FACTOR D;

EID: 77950585593     PISSN: 15345807     EISSN: 18781551     Source Type: Journal    
DOI: 10.1016/j.devcel.2010.01.009     Document Type: Article

References (49)

1. Abtahian, F., Guerriero, A., Sebzda, E., Lu, M.M., Zhou, R., Mocsai, A., Myers, E.E., Huang, B., Jackson, D.G., Ferrari, V.A., et al. Regulation of blood and lymphatic vascular separation by signaling proteins SLP-76 and Syk. Science 299 (2003), 247–251.
2. Achen, M.G., Williams, R.A., Minekus, M.P., Thornton, G.E., Stenvers, K., Rogers, P.A., Lederman, F., Roufail, S., Stacker, S.A., Localization of vascular endothelial growth factor-D in malignant melanoma suggests a role in tumour angiogenesis. J. Pathol. 193 (2001), 147–154.
3. Adams, R.H., Alitalo, K., Molecular regulation of angiogenesis and lymphangiogenesis. Nat. Rev. Mol. Cell Biol. 8 (2007), 464–478.
4. Alitalo, K., Tammela, T., Petrova, T.V., Lymphangiogenesis in development and human disease. Nature 438 (2005), 946–953.
5. Avantaggiato, V., Orlandini, M., Acampora, D., Oliviero, S., Simeone, A., Embryonic expression pattern of the murine figf gene, a growth factor belonging to platelet-derived growth factor/vascular endothelial growth factor family. Mech. Dev. 73 (1998), 221–224.
6. Backhed, F., Crawford, P.A., O'Donnell, D., Gordon, J.I., Postnatal lymphatic partitioning from the blood vasculature in the small intestine requires fasting-induced adipose factor. Proc. Natl. Acad. Sci. USA 104 (2007), 606–611.
7. Baldwin, M.E., Halford, M.M., Roufail, S., Williams, R.A., Hibbs, M.L., Grail, D., Kubo, H., Stacker, S.A., Achen, M.G., Vascular endothelial growth factor D is dispensable for development of the lymphatic system. Mol. Cell. Biol. 25 (2005), 2441–2449.
8. Baluk, P., Tammela, T., Ator, E., Lyubynska, N., Achen, M.G., Hicklin, D.J., Jeltsch, M., Petrova, T.V., Pytowski, B., Stacker, S.A., et al. Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation. J. Clin. Invest. 115 (2005), 247–257.
9. Cheng, A.M., Rowley, B., Pao, W., Hayday, A., Bolen, J.B., Pawson, T., Syk tyrosine kinase required for mouse viability and B-cell development. Nature 378 (1995), 303–306.
10. Cueni, L.N., Detmar, M., New insights into the molecular control of the lymphatic vascular system and its role in disease. J. Invest. Dermatol. 126 (2006), 2167–2177.
11. Cursiefen, C., Chen, L., Borges, L.P., Jackson, D., Cao, J., Radziejewski, C., D'Amore, P.A., Dana, M.R., Wiegand, S.J., Streilein, J.W., VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J. Clin. Invest. 113 (2004), 1040–1050.
12. Dellinger, M., Hunter, R., Bernas, M., Gale, N., Yancopoulos, G., Erickson, R., Witte, M., Defective remodeling and maturation of the lymphatic vasculature in Angiopoietin-2 deficient mice. Dev. Biol. 319 (2008), 309–320.
13. Enholm, B., Karpanen, T., Jeltsch, M., Kubo, H., Stenback, F., Prevo, R., Jackson, D.G., Yla-Herttuala, S., Alitalo, K., Adenoviral expression of vascular endothelial growth factor-C induces lymphangiogenesis in the skin. Circ. Res. 88 (2001), 623–629.
14. Fu, J., Gerhardt, H., McDaniel, J.M., Xia, B., Liu, X., Ivanciu, L., Ny, A., Hermans, K., Silasi-Mansat, R., McGee, S., et al. Endothelial cell O-glycan deficiency causes blood/lymphatic misconnections and consequent fatty liver disease in mice. J. Clin. Invest. 118 (2008), 3725–3737.
15. Gale, N.W., Thurston, G., Hackett, S.F., Renard, R., Wang, Q., McClain, J., Martin, C., Witte, C., Witte, M.H., Jackson, D., et al. Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1. Dev. Cell 3 (2002), 411–423.
16. Haiko, P., Makinen, T., Keskitalo, S., Taipale, J., Karkkainen, M.J., Baldwin, M.E., Stacker, S.A., Achen, M.G., Alitalo, K., Deletion of vascular endothelial growth factor C (VEGF-C) and VEGF-D is not equivalent to VEGF receptor 3 deletion in mouse embryos. Mol. Cell. Biol. 28 (2008), 4843–4850.
17. Ichise, H., Ichise, T., Ohtani, O., Yoshida, N., Phospholipase C{γ}2 is necessary for separation of blood and lymphatic vasculature in mice. Development 136 (2009), 191–195.
18. Johnson, N.C., Dillard, M.E., Baluk, P., McDonald, D.M., Harvey, N.L., Frase, S.L., Oliver, G., Lymphatic endothelial cell identity is reversible and its maintenance requires Prox1 activity. Genes Dev. 22 (2008), 3282–3291.
19. Karkkainen, M.J., Haiko, P., Sainio, K., Partanen, J., Taipale, J., Petrova, T.V., Jeltsch, M., Jackson, D.G., Talikka, M., Rauvala, H., et al. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat. Immunol. 5 (2004), 74–80.
20. Kiefer, F., Brumell, J., Al-Alawi, N., Latour, S., Cheng, A., Veillette, A., Grinstein, S., Pawson, T., The Syk protein tyrosine kinase is essential for Fcγ receptor signaling in macrophages and neutrophils. Mol. Cell. Biol. 18 (1998), 4209–4220.
21. Kukk, E., Lymboussaki, A., Taira, S., Kaipainen, A., Jeltsch, M., Joukov, V., Alitalo, K., VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development. Development 122 (1996), 3829–3837.
22. Latour, S., Veillette, A., Proximal protein tyrosine kinases in immunoreceptor signaling. Curr. Opin. Immunol. 13 (2001), 299–306.
23. Lehr, H.A., Leunig, M., Menger, M.D., Nolte, D., Messmer, K., Dorsal skinfold chamber technique for intravital microscopy in nude mice. Am. J. Pathol. 143 (1993), 1055–1062.
24. Lohela, M., Helotera, H., Haiko, P., Dumont, D.J., Alitalo, K., Transgenic induction of vascular endothelial growth factor-C is strongly angiogenic in mouse embryos but leads to persistent lymphatic hyperplasia in adult tissues. Am. J. Pathol. 173 (2008), 1891–1901.
25. Machnik, A., Neuhofer, W., Jantsch, J., Dahlmann, A., Tammela, T., Machura, K., Park, J.K., Beck, F.X., Muller, D.N., Derer, W., et al. Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C-dependent buffering mechanism. Nat. Med. 15 (2009), 545–552.
26. Makinen, T., Jussila, L., Veikkola, T., Karpanen, T., Kettunen, M.I., Pulkkanen, K.J., Kauppinen, R., Jackson, D.G., Kubo, H., Nishikawa, S., et al. Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3. Nat. Med. 7 (2001), 199–205.
27. Makinen, T., Adams, R.H., Bailey, J., Lu, Q., Ziemiecki, A., Alitalo, K., Klein, R., Wilkinson, G.A., PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature. Genes Dev. 19 (2005), 397–410.
28. Mantovani, A., Sica, A., Sozzani, S., Allavena, P., Vecchi, A., Locati, M., The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25 (2004), 677–686.
29. Morisada, T., Oike, Y., Yamada, Y., Urano, T., Akao, M., Kubota, Y., Maekawa, H., Kimura, Y., Ohmura, M., Miyamoto, T., et al. Angiopoietin-1 promotes LYVE-1-positive lymphatic vessel formation. Blood 105 (2005), 4649–4656.
30. Ny, A., Koch, M., Vandevelde, W., Schneider, M., Fischer, C., Diez-Juan, A., Neven, E., Geudens, I., Maity, S., Moons, L., et al. Role of VEGF-D and VEGFR-3 in developmental lymphangiogenesis, a chemicogenetic study in Xenopus tadpoles. Blood 112 (2008), 1740–1749.
31. Oliver, G., Lymphatic vasculature development. Nat. Rev. Immunol. 4 (2004), 35–45.
32. Palacios, E.H., Weiss, A., Distinct roles for Syk and ZAP-70 during early thymocyte development. J. Exp. Med. 204 (2007), 1703–1715.
33. Pucci, F., Venneri, M.A., Biziato, D., Nonis, A., Moi, D., Sica, A., Di, S.C., Naldini, L., De Palma, M., A distinguishing gene signature shared by tumor-infiltrating Tie2-expressing monocytes, blood ‘resident’ monocytes, and embryonic macrophages suggests common functions and developmental relationships. Blood 114 (2009), 901–914.
34. Ramirez, M.I., Millien, G., Hinds, A., Cao, Y., Seldin, D.C., Williams, M.C., T1α a lung type I cell differentiation gene, is required for normal lung cell proliferation and alveolus formation at birth. Dev. Biol. 256 (2003), 61–72.
35. Schacht, V., Ramirez, M.I., Hong, Y.K., Hirakawa, S., Feng, D., Harvey, N., Williams, M., Dvorak, A.M., Dvorak, H.F., Oliver, G., Detmar, M., T1α/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema. EMBO J. 22 (2003), 3546–3556.
36. Schoppmann, S.F., Birner, P., Stockl, J., Kalt, R., Ullrich, R., Caucig, C., Kriehuber, E., Nagy, K., Alitalo, K., Kerjaschki, D., Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. Am. J. Pathol. 161 (2002), 947–956.
37. Sebzda, E., Hibbard, C., Sweeney, S., Abtahian, F., Bezman, N., Clemens, G., Maltzman, J.S., Cheng, L., Liu, F., Turner, M., et al. Syk and slp-76 mutant mice reveal a cell-autonomous hematopoietic cell contribution to vascular development. Dev. Cell 11 (2006), 349–361.
38. Soriano, P., Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat. Genet. 21 (1999), 70–71.
39. Srinivas, S., Watanabe, T., Lin, C.S., William, C.M., Tanabe, Y., Jessell, T.M., Costantini, F., Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Dev. Biol., 1, 2001, 4.
40. Suzuki-Inoue, K., Fuller, G.L., Garcia, A., Eble, J.A., Pohlmann, S., Inoue, O., Gartner, T.K., Hughan, S.C., Pearce, A.C., Laing, G.D., et al. A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2. Blood 107 (2006), 542–549.
41. Suzuki-Inoue, K., Kato, Y., Inoue, O., Kaneko, M.K., Mishima, K., Yatomi, Y., Yamazaki, Y., Narimatsu, H., Ozaki, Y., Involvement of the snake toxin receptor CLEC-2, in podoplanin-mediated platelet activation, by cancer cells. J. Biol. Chem. 282 (2007), 25993–26001.
42. Tammela, T., Saaristo, A., Lohela, M., Morisada, T., Tornberg, J., Norrmen, C., Oike, Y., Pajusola, K., Thurston, G., Suda, T., et al. Angiopoietin-1 promotes lymphatic sprouting and hyperplasia. Blood 105 (2005), 4642–4648.
43. Taniguchi, K., Kohno, R., Ayada, T., Kato, R., Ichiyama, K., Morisada, T., Oike, Y., Yonemitsu, Y., Maehara, Y., Yoshimura, A., Spreds are essential for embryonic lymphangiogenesis by regulating vascular endothelial growth factor receptor 3 signaling. Mol. Cell. Biol. 27 (2007), 4541–4550.
44. Turnbull, I.R., Colonna, M., Activating and inhibitory functions of DAP12. Nat. Rev. Immunol. 7 (2007), 155–161.
45. Turner, M., Mee, P.J., Costello, P.S., Williams, O., Price, A.A., Duddy, L.P., Furlong, M.T., Geahlen, R.L., Tybulewicz, V.L., Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk. Nature 378 (1995), 298–302.
46. Turner, M., Schweighoffer, E., Colucci, F., Di Santo, J.P., Tybulewicz, V.L., Tyrosine kinase SYK: essential functions for immunoreceptor signalling. Immunol. Today 21 (2000), 148–154.
47. Veikkola, T., Jussila, L., Makinen, T., Karpanen, T., Jeltsch, M., Petrova, T.V., Kubo, H., Thurston, G., McDonald, D.M., Achen, M.G., et al. Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice. EMBO J. 20 (2001), 1223–1231.
48. Wigle, J.T., Oliver, G., Prox1 function is required for the development of the murine lymphatic system. Cell 98 (1999), 769–778.
49. Zhang, Y., Muyrers, J.P., Testa, G., Stewart, A.F., DNA cloning by homologous recombination in Escherichia coli. Nat. Biotechnol. 18 (2000), 1314–1317.